February 27th, 2025 |
Jeffrey Jones |
Chief Medical Officer |
Sale
|
4.89K |
$41.75K |
174.16K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
4895 |
$8.53 |
$41.75K |
|
February 27th, 2025 |
Nadim Ahmed |
Director, Officer: President And CEO |
Sale
|
12.53K |
$106.87K |
430.62K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
12529 |
$8.53 |
$106.87K |
|
February 27th, 2025 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
3.76K |
$32.04K |
142.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
3756 |
$8.53 |
$32.04K |
|
February 27th, 2025 |
Jacquelyn Sumer |
Chief Legal Officer |
Sale
|
3.76K |
$32.04K |
136.90K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
3756 |
$8.53 |
$32.04K |
|
February 21st, 2025 |
Jennifer Michaelson |
Chief Scientific Officer |
Stock Award
|
150.00K |
$943.00K |
145.76K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
50000 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
100000 |
$9.43 |
$943.00K |
|
February 21st, 2025 |
Corrine Savill |
Chief Business Officer |
Stock Award
|
112.50K |
$707.25K |
240.99K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
37500 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
75000 |
$9.43 |
$707.25K |
|
February 21st, 2025 |
Jacquelyn Sumer |
Chief Legal Officer |
Stock Award
|
150.00K |
$943.00K |
140.65K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
50000 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
100000 |
$9.43 |
$943.00K |
|
February 21st, 2025 |
Nadim Ahmed |
Director, Officer: President And CEO |
Stock Award
|
540.00K |
$3.39M |
443.15K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
180000 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
360000 |
$9.43 |
$3.39M |
|
February 21st, 2025 |
Jeffrey Jones |
Chief Medical Officer |
Stock Award
|
195.00K |
$1.23M |
179.06K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
65000 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
130000 |
$9.43 |
$1.23M |
|
February 21st, 2025 |
Mary Fenton |
Chief Financial Officer |
Stock Award
|
180.00K |
$1.13M |
120.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
120000 |
$9.43 |
$1.13M |
Common Stock |
Stock Award
|
60000 |
$0.00 |
$- |
|
January 7th, 2025 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
4.00K |
$50.04K |
95.76K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
4000 |
$12.51 |
$50.04K |
|
December 27th, 2024 |
Nadim Ahmed |
Director, Officer: President And CEO |
Sale
|
8.40K |
$99.71K |
263.15K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
8400 |
$11.87 |
$99.71K |
|
December 20th, 2024 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
4.69K |
$53.55K |
99.76K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
4693 |
$11.41 |
$53.55K |
|
December 20th, 2024 |
Jeffrey Jones |
Chief Medical Officer |
Sale
|
4.63K |
$52.85K |
114.06K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
4632 |
$11.41 |
$52.85K |
|
December 20th, 2024 |
Jacquelyn Sumer |
Chief Legal Officer |
Sale
|
3.48K |
$39.73K |
90.65K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
3482 |
$11.41 |
$39.73K |
|
December 16th, 2024 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
3.49K |
$43.68K |
104.45K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
3489 |
$12.52 |
$43.68K |
|
November 7th, 2024 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
8.00K |
$125.12K |
107.94K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
8000 |
$15.64 |
$125.12K |
|
September 9th, 2024 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
8.00K |
$144.72K |
115.94K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
8000 |
$18.09 |
$144.72K |
|
August 9th, 2024 |
Mary Thistle |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
August 9th, 2024 |
Mary Thistle |
Director |
Stock Award
|
25.74K |
$421.67K |
25.74K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
25743 |
$16.38 |
$421.67K |
|
July 9th, 2024 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
8.00K |
$130.64K |
123.94K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
8000 |
$16.33 |
$130.64K |
|
July 2nd, 2024 |
Jennifer Michaelson |
Chief Scientific Officer |
Stock Award
|
2.36K |
$21.24K |
131.94K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
2360 |
$9.00 |
$21.24K |
|
June 27th, 2024 |
Stephen Webster |
Director |
Stock Award
|
15.81K |
$260.80K |
15.81K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
15806 |
$16.50 |
$260.80K |
|
June 27th, 2024 |
Anthony Rosenberg |
Director |
Stock Award
|
15.81K |
$260.80K |
15.81K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
15806 |
$16.50 |
$260.80K |
|
June 27th, 2024 |
Anne-marie Martin |
Director |
Stock Award
|
15.81K |
$260.80K |
15.81K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
15806 |
$16.50 |
$260.80K |
|
June 27th, 2024 |
David Ryan |
Director |
Stock Award
|
15.81K |
$260.80K |
15.81K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
15806 |
$16.50 |
$260.80K |
|
June 11th, 2024 |
Thomas Ebeling |
Director |
Exercise
|
36.90K |
$479.70K |
186.65K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
18450 |
$13.00 |
$239.85K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
18450 |
$13.00 |
$239.85K |
|
May 23rd, 2024 |
Thomas Ebeling |
Director |
Stock Award Exercise
|
201.40K |
$1.14M |
168.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
16475 |
$12.73 |
$209.73K |
Common Stock |
Stock Award
|
84224 |
$4.30 |
$362.16K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
84224 |
$4.30 |
$362.16K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
16475 |
$12.73 |
$209.73K |
|
May 16th, 2024 |
David Meek |
Director |
Stock Award
|
15.62K |
$417.31K |
15.62K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
15618 |
$26.72 |
$417.31K |
|
May 16th, 2024 |
David Meek |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
May 8th, 2024 |
Jennifer Michaelson |
Chief Scientific Officer |
Exercise Sale
|
174.82K |
$2.27M |
187.58K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
50000 |
$4.30 |
$215.00K |
Common Stock |
Sale
|
37723 |
$27.82 |
$1.05M |
Stock Option (Right to Buy) |
Exercise/Conversion
|
50000 |
$4.30 |
$215.00K |
Common Stock |
Exercise/Conversion
|
5606 |
$4.30 |
$24.11K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
5606 |
$4.30 |
$24.11K |
Common Stock |
Sale
|
5606 |
$30.06 |
$168.52K |
Common Stock |
Sale
|
20277 |
$28.54 |
$578.71K |
|
April 30th, 2024 |
Mary Fenton |
Chief Financial Officer |
Stock Award
|
200.00K |
$5.42M |
200.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
200000 |
$27.12 |
$5.42M |
|
April 30th, 2024 |
Mary Fenton |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
April 2nd, 2024 |
Nate Nguyen |
Interim Pao And Pfo |
|
191.00K |
$5.25M |
13.38K |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
|
0 |
$0.00 |
$- |
Common Stock |
|
0 |
$0.00 |
$- |
Stock Option (Right to Buy) |
|
62500 |
$13.60 |
$850.00K |
Stock Option (Right to Buy) |
|
26750 |
$17.54 |
$469.19K |
Stock Option (Right to Buy) |
|
26750 |
$11.34 |
$303.35K |
Stock Option (Right to Buy) |
|
75000 |
$48.39 |
$3.63M |
|
February 23rd, 2024 |
Corrine Savill |
Chief Business Officer |
Stock Award
|
112.50K |
$1.32M |
203.49K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
37500 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
75000 |
$17.54 |
$1.32M |
|
February 23rd, 2024 |
Nadim Ahmed |
Director, Officer: President And CEO |
Stock Award
|
480.00K |
$5.61M |
320.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
320000 |
$17.54 |
$5.61M |
Common Stock |
Stock Award
|
160000 |
$0.00 |
$- |
|
February 23rd, 2024 |
Jeffrey Trigilio |
Chief Financial Officer |
Stock Award
|
150.00K |
$1.75M |
133.92K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
50000 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
100000 |
$17.54 |
$1.75M |
|
February 23rd, 2024 |
Jeffrey Jones |
Chief Medical Officer |
Stock Award
|
187.50K |
$2.19M |
125.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
125000 |
$17.54 |
$2.19M |
Common Stock |
Stock Award
|
62500 |
$0.00 |
$- |
|
February 23rd, 2024 |
Jennifer Michaelson |
Chief Scientific Officer |
Stock Award
|
150.00K |
$1.75M |
137.58K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
50000 |
$0.00 |
$- |
Stock Option (Right to Buy) |
Stock Award
|
100000 |
$17.54 |
$1.75M |
|
February 23rd, 2024 |
Jacquelyn Sumer |
Chief Legal Officer |
Stock Award
|
150.00K |
$1.75M |
100.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
100000 |
$17.54 |
$1.75M |
Common Stock |
Stock Award
|
50000 |
$0.00 |
$- |
|
February 2nd, 2024 |
Corrine Savill |
Chief Business Officer |
Exercise Sale
|
120.00K |
$991.20K |
205.99K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
40000 |
$4.30 |
$172.00K |
Common Stock |
Sale
|
40000 |
$16.18 |
$647.20K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
40000 |
$4.30 |
$172.00K |
|
January 30th, 2024 |
Corrine Savill |
Chief Business Officer |
Exercise Sale
|
120.00K |
$907.60K |
205.99K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
40000 |
$4.30 |
$172.00K |
Common Stock |
Sale
|
40000 |
$14.09 |
$563.60K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
26003 |
$4.30 |
$111.81K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
13997 |
$4.30 |
$60.19K |
|
January 24th, 2024 |
Corrine Savill |
Chief Business Officer |
Exercise Sale
|
111.75K |
$801.03K |
187.31K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
21316 |
$4.30 |
$91.66K |
Common Stock |
Exercise/Conversion
|
14559 |
$4.30 |
$62.60K |
Common Stock |
Sale
|
14559 |
$12.18 |
$177.33K |
Common Stock |
Sale
|
4125 |
$12.02 |
$49.58K |
Common Stock |
Sale
|
21316 |
$12.46 |
$265.60K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
14559 |
$4.30 |
$62.60K |
Stock Option (Right to Buy) |
Exercise/Conversion
|
21316 |
$4.30 |
$91.66K |
|
December 27th, 2023 |
Nadim Ahmed |
Director, Officer: President And CEO |
Sale
|
4.27K |
$39.47K |
111.55K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
4272 |
$9.24 |
$39.47K |
|
December 22nd, 2023 |
Jeffrey Jones |
Chief Medical Officer |
Sale
|
1.86K |
$15.81K |
56.19K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1860 |
$8.50 |
$15.81K |
|
December 22nd, 2023 |
Jacquelyn Sumer |
Chief Legal Officer |
Sale
|
1.40K |
$11.90K |
44.13K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1400 |
$8.50 |
$11.90K |
|
December 22nd, 2023 |
Jeffrey Trigilio |
Chief Financial Officer |
Sale
|
1.92K |
$16.32K |
83.92K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1920 |
$8.50 |
$16.32K |
|
December 22nd, 2023 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
1.15K |
$9.73K |
87.58K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1145 |
$8.50 |
$9.73K |
|
December 20th, 2023 |
Jeffrey Jones |
Chief Medical Officer |
Sale
|
386 |
$3.17K |
58.05K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
386 |
$8.22 |
$3.17K |
|
December 20th, 2023 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
238 |
$1.96K |
88.73K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
238 |
$8.22 |
$1.96K |
|
December 20th, 2023 |
Jacquelyn Sumer |
Chief Legal Officer |
Sale
|
290 |
$2.38K |
45.53K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
290 |
$8.22 |
$2.38K |
|
December 20th, 2023 |
Jeffrey Trigilio |
Chief Financial Officer |
Sale
|
398 |
$3.27K |
85.84K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
398 |
$8.22 |
$3.27K |
|
December 13th, 2023 |
Jeffrey Trigilio |
Chief Financial Officer |
Sale
|
1.93K |
$15.04K |
86.24K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1926 |
$7.81 |
$15.04K |
|
December 13th, 2023 |
Jennifer Michaelson |
Chief Scientific Officer |
Sale
|
1.07K |
$8.34K |
88.97K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1068 |
$7.81 |
$8.34K |
|
July 5th, 2023 |
Jeffrey Trigilio |
Chief Financial Officer |
Stock Award
|
2.34K |
$21.25K |
88.16K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
2340 |
$9.08 |
$21.25K |
|
June 29th, 2023 |
Nadim Ahmed |
Director, Officer: President And CEO |
Sale
|
759 |
$8.65K |
115.82K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
759 |
$11.40 |
$8.65K |
|
June 21st, 2023 |
Jeffrey Jones |
Chief Medical Officer |
Sale
|
387 |
$5.01K |
58.44K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
387 |
$12.94 |
$5.01K |
|
June 21st, 2023 |
Jennifer Michaelson |
Chief Development Officer |
Sale
|
238 |
$3.08K |
90.03K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
238 |
$12.94 |
$3.08K |
|
June 21st, 2023 |
Jeffrey Trigilio |
Chief Financial Officer |
Sale
|
399 |
$5.16K |
85.82K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
399 |
$12.94 |
$5.16K |
|
June 21st, 2023 |
Jacquelyn Sumer |
Chief Legal Officer |
Sale
|
291 |
$3.77K |
45.82K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
291 |
$12.94 |
$3.77K |
|
June 14th, 2023 |
Jeffrey Trigilio |
Chief Financial Officer |
Sale
|
319 |
$4.18K |
86.22K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
319 |
$13.11 |
$4.18K |
|
June 14th, 2023 |
Jennifer Michaelson |
Chief Development Officer |
Sale
|
176 |
$2.31K |
90.27K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
176 |
$13.11 |
$2.31K |
|